Uganda Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Sell more software Get listed in the HRIS directory of software vendors. Get seen by 12,000+ monthly unique visitors. Sign up today. From our sponsors

Uganda Pharmaceuticals and Healthcare Report Q4 2013 Sep 11th 2013, 00:00, by rnrmahesh BMI View: Investment into Uganda’s pharmaceuticals and healthcare sector by companies to meet the demand for healthcare services is an advisable business strategy – as highlighted by the high growth forecast in healthcare spending between 2012 and 2017. However, we note that there are downside risks to our forecast. These include low affordability levels, inadequate healthcare infrastructure and inefficient supply chain systems, which will ultimately inhibit drugmakers’ revenue-earning abilities. Headline Expenditure Projections ? Pharmaceuticals: UGX831.90bn (US$332mn) in 2012 to UGX926.84(US$348mn) in 2013; +11.4% growth in local currency terms and +4.2% in US dollar terms. ? Healthcare: UGX4,154.02bn (US$1.66bn) in 2012 … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=114583. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/uganda-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions